BERBERINE INDUCED TORSADES DE POINTES (TDP)
Open accessThe DOI matches its Crossref record.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“it also exerts pharmacodynamic effects that can add to those of numerous therapeutic classes [38,39,40].”
From Berberine-Drug Interactions: Mechanisms, Clinical Relevance and Risk Stratification-A Narrative Review (2026) · cites this paper as [39]
In the citing paper
“The risk increases when berberine is combined with other drugs that prolong QT or that inhibit its metabolism, producing a pharmacokinetic and pharmacodynamic “double hit” [39,91]”
From Berberine-Drug Interactions: Mechanisms, Clinical Relevance and Risk Stratification-A Narrative Review (2026) · cites this paper as [39]
In the citing paper
“A further signal has been reported at the conference-abstract level; the small number of cases warrants caution in interpretation [39].”
From Berberine-Drug Interactions: Mechanisms, Clinical Relevance and Risk Stratification-A Narrative Review (2026) · cites this paper as [39]
In the citing paper
“Controlled clinical pharmacokinetic studies in humans are lacking for the berberine–victim-drug pairs at the highest theoretical risk, such as tacrolimus, warfarin and QT-prolonging substrates [39,63].”
From Berberine-Drug Interactions: Mechanisms, Clinical Relevance and Risk Stratification-A Narrative Review (2026) · cites this paper as [39]
In the citing paper
“The clinical anchor evidence on cyclosporine and the torsades de pointes signals compel a reassessment of the perception of harmlessness [39,118].”
From Berberine-Drug Interactions: Mechanisms, Clinical Relevance and Risk Stratification-A Narrative Review (2026) · cites this paper as [39]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cited by
Cardiovascular toxicity associated with supplement use
Corcoran, J. N. (2025) · Clinical Toxicology · doi:10.1080/15563650.2025.2550983 · Cited by 5
“Blockade of the human ether-à-go-gorelated gene (herg) encoded I kr current, such as occurs with berberine, can lead to Qt prolongation and potentially torsade de pointes [30,31].”
Dumitru, C. N., Marcu, T., Dumitru, A. O., Tudor, S. S., Ferțu, I. D., Elisei, A.-M., & Goroftei, L. (2026) · Pharmaceuticals · doi:10.3390/ph19081313 · Cited by 2
“…local concentrations that inhibit CYP3A4/CYP2D6/CYP2C9, and can even induce CYP3A4 transcriptionally, and that modulate P-glycoprotein and organic cation transporters [35,59,65]; superimposed on these are additive pharmacodynamic effects, including hERG-channel block with QT prolongation [39,84].”
InfluentialWilliams, J. M., Yadlapalli, N., & Franchi, F. (2026) · Cureus · doi:10.7759/cureus.111276
Metadata
- Authors
- Rafique, S., Missula, K., Cheema, A., Salih, M., & Labedi, M. R.
- Affiliations
- SIU Medicine (US)
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2025-04
- Volume
- 85
- Issue
- 12
- Pages
- 3564
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W4408988236
- Cited by
- 4
- References
- 0
- Citations by year
- 2026: 2 · 2025: 2
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 365 d)
- Locations
- Journal of the American College of Cardiology (publishedVersion, cc-by-nc-nd)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Pharmacology (medical) › Berberine and alkaloids research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Keywords
- berberine, torsades de pointes, drug-induced arrhythmia, QT prolongation, antiarrhythmic drugs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: BERBERINE INDUCED TORSADES DE POINTES (TDP). https://app.cochat.ai/papers/10.1016/s0735-1097(25)04048-3
- The paper
- Rafique, S., Missula, K., Cheema, A., Salih, M., & Labedi, M. R. (2025). BERBERINE INDUCED TORSADES DE POINTES (TDP). Journal of the American College of Cardiology. https://doi.org/10.1016/s0735-1097(25)04048-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.